Phio Pharmaceuticals Corp. (PHIO)
1.085
+0.02
(+1.40%)
USD |
NASDAQ |
May 18, 15:19
Phio Pharmaceuticals EPS Diluted (Quarterly) : -0.3446 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | -2.932 |
| MetaVia, Inc. | -0.7867 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.003M |
| Total Expenses (Quarterly) | 4.003M |
| Enterprise Value | -4.600M |
| Earnings Yield | -132.5% |
| Normalized Earnings Yield | -132.52 |